Background: A National human papilloma virus (HPV) Vaccination Programme for the
prevention of HPV infection and associated disease using the quadrivalent HPV vaccine …

In head and neck cancer (HNC), some subsites are associated with human papillomavirus
(HPV) infection, whereas others are unrelated. Although studies have demonstrated the …

High-risk human papillomavirus (HPV) positive squamous cell carcinoma (SCC) of the head
and neck is reported most commonly in the oropharynx but can also uncommonly be found …

Objective To evaluate the epidemiological profile and survival rate of oral and
oropharyngeal cancer patients seen at a university hospital. Methods A cross-sectional …

Background The magnitude of the growing burden of oropharyngeal cancers (OPC), a sub-
set of head and neck cancers (HNC), is unknown in England. Methods Data were extracted …

Background Lip, oral cavity, and oropharyngeal squamous cell carcinoma (SCC) represent
a major health problem in the global scenario. In South America, the highest incidence rates …

There is a global increase in the prevalence of human papillomavirus (HPV)‐driven
oropharyngeal squamous cell carcinoma (OPSCC) in Australia and New Zealand. Risk …

High-risk (HR) human papillomavirus (HPV) infection is recognized as a primary etiologic
factor of anogenital cancers and more recently of a subgroup of oropharyngeal squamous …

The incidence of human papillomavirus (HPV)-positive oropharyngeal cancer (OPC) is
rising in high-income countries, including Australia. Increasing evidence suggests that …

Background The last decade has seen changes in the epidemiology of mucosal squamous
cell carcinomas of the head and neck (HNSCCs), with increasing numbers of cases …